| Accession number;99A0894036 |
| Title;The Use of Rectal Misoprostol as Active Pharmacological Management of the Third Stage of Labor. |
| Author;DIAB K M(Ain Shams Univ., Cairo, Egy) RAMY A R(Ain Shams Univ., Cairo, Egy) YEHIA M A(Ain Shams Univ., Cairo, Egy) |
Journal Title;J Obstet Gynaecol Res
|
Journal Code:Y0696A
|
ISSN:1341-8076
|
|
VOL.25;NO.5;PAGE.327-332(1999)
|
| Figure&Table&Reference;TBL.4, REF.25 |
| Pub. Country;Japan |
| Language;English |
| Abstract;Objective: To compare the effectiveness of rectal Misoprostol versus combined intramuscular oxytocin and ergometrine (O-E) in the management of the third stage of labor. Methods: Low-risk women in 3rd stage of labor were allocated to receive either rectal Misoprostol [200 ug (n = 25), 400 ug (n = 45)] or 5-units oxytocin and 0.2 mg ergometrine intramuscularly (n = 75). Clinical and hematological parameters were compared using t and chi-square tests. Results: Both groups were well matched and had similar duration of the 3rd-stage of labor. Misoprostol users had lower 3rd-stage estimated blood loss and needed less further ecbolics compared to O-E group. Postpartum Hb and Hct levels were significantly lower in O-E group than Misoprostol group. Postpartum hypertension occurred more in O-E group. Subjects in Misoprostol group had more shivering. Subjects receiving 200 ug and 400 ug Misoprostol had similar outcome variables. Conclusion: Rectal Misoprostol may be used safely in the management of the third stage of labor. (author abst.) |
|
